E-mailhongquchem@qq.com

  • Home
  • About Us
  • Products
    • Inhibitor
    • Impurities
    • Intermediate
    • Others
  • News
  • Custom Synthesis
  • Contact Us

Home> News

News

  • Suspected of price manipulation, 26 generic pharmaceutical companies, including Sanders, TIWA and mylan, have been sued

    Suspected of price manipulation, 26 generic pharmaceutical companies, including Sanders, TIWA and mylan, have been sued by states in the United States!

    2020-06-12

  • 278 million dollars! Takeda's Asia Pacific rights to sell 18 drugs to celltrion

    278 million dollars! Takeda\'s Asia Pacific rights to sell 18 drugs to celltrion

    2020-06-12

  • Too high NDMA level in metformin! FDA requires 5 companies to recall

    Too high NDMA level in metformin! FDA requires 5 companies to recall

    2020-05-29

  • Loxo-292 approved! Retevmo (selpercatinib), an FDA approved Lilly RET inhibitor, for lung and thyroid cancer patients

    Loxo-292 approved! Retevmo (selpercatinib), an FDA approved Lilly RET inhibitor, for lung and thyroid cancer patients

    2020-05-09

  • Good news! Hqp1351, the core product under development of AXA pharmaceutical, has obtained the qualification of fast tra

    Good news! Hqp1351, the core product under development of AXA pharmaceutical, has obtained the qualification of fast track for FDA review, and meets the milestone again

    2020-05-09

  • Spinal muscular atrophy (SMA) the first oral medicine! Roche risdiplam's US review has been delayed for 3 months, and wi

    Spinal muscular atrophy (SMA) the first oral medicine! Roche risdiplam\'s US review has been delayed for 3 months, and will soon submit an application for listing in China!

    2020-04-29

  • The first gene therapy for spinal muscular atrophy (SMA) in the world! Zolgensma of Novartis is recommended and approved

    The first gene therapy for spinal muscular atrophy (SMA) in the world! Zolgensma of Novartis is recommended and approved by CHMP of EU!

    2020-04-29

  • [recruitment of gastric cancer patients] Clinical Study of hx008 injection combined with chemotherapy in the treatment o

    [recruitment of gastric cancer patients] Clinical Study of hx008 injection combined with chemotherapy in the treatment of advanced gastric cancer

    2020-04-25

  • 共31条数据
  • 上一页
  • 1
  • 2
  • 3
  • 4
  • 下一页
    • About Us
    • About Us
    • Products
    • Inhibitor
    • Impurities
    • Intermediate
    • Others
    • Contact Us
    • Contact Us

Shanghai Hongqu Biomedical Technolog

Tel:

qq:765099555

Email:hongquchem@qq.com

Add:Room 3122, No. 3108, fengzhe Road, Qingcun Town, Fengxian District, Shanghai

Official WeChat

Links: friendlink friendlink

©2020-2030 all rights reserved
  • E-MAIL

  • QQ

  • TEL